temozolomide has been researched along with 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, Y; Guo, Q; Huang, S; Li, Z; Liao, Y; Ma, R; Tan, R; Wei, M; Zhang, L; Zhao, L | 1 |
| Ding, Y; Li, Z; Qin, H; Xu, Q; Yang, Y; Zhang, H; Zhao, L; Zhou, Y | 1 |
2 other study(ies) available for temozolomide and 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one
| Article | Year |
|---|---|
Oroxylin A increases the sensitivity of temozolomide on glioma cells by hypoxia-inducible factor 1α/hedgehog pathway under hypoxia.
Topics: Animals; Brain Neoplasms; Cell Movement; Cell Proliferation; Flavonoids; Gene Expression Regulation, Neoplastic; Glioma; Hedgehog Proteins; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Rats; Signal Transduction; Temozolomide; Tumor Microenvironment | 2019 |
Oroxylin A reversed Fibronectin-induced glioma insensitivity to Temozolomide by suppressing IP
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; beta Catenin; Biomarkers, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Female; Fibronectins; Flavonoids; Gene Expression Regulation, Neoplastic; Glioma; Humans; Inositol 1,4,5-Trisphosphate Receptors; Mice; Mice, Inbred BALB C; Mice, Nude; Proto-Oncogene Proteins c-akt; Temozolomide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |